Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells

被引:36
作者
Ewald, JA [1 ]
Wilkinson, JC [1 ]
Guyer, CA [1 ]
Staros, JV [1 ]
机构
[1] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA
关键词
D O I
10.1016/S0014-4827(02)00014-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the intrinsic activities of the epidermal growth factor receptor and the role of its kinase domain in these functions within a cellular environment lacking endogenous ErbB protein expression, wild-type EGF receptor (WT-EGFR) and two kinase-impaired mutants, D813A and K721R, were expressed in 32D murine hematopoietic cells, a line which is normally dependent on interleukin 3 (IL3) for growth and survival. Addition of EGF in the absence of IL3 stimulates receptor autophosphorylation and, in the presence of serum, mitosis in cells expressing WT-EGFR, but not in cells expressing D813A or K721R. Unexpectedly, cells expressing WT-EGFR or K721R exhibited IL3-independent survival in the presence of fetal bovine serum; parental 32D cells and cells expressing D813A did not survive, apparently undergoing apoptosis in the absence of IL3, whether or not serum was present. Addition of EGF did not prevent the apoptosis of WT-EGFR or K721R cells in serum-free medium. Activation of Akt was not necessary to mediate the prosurvival activity of EGF receptor expression. These results suggest that the EGF receptor can mediate the prevention of apoptosis independently of both receptor-ligand binding and receptor kinase activity, and this activity is disrupted by the D813A mutation. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:121 / 131
页数:11
相关论文
共 63 条
[1]  
Adamson ED, 1997, CURR TOP DEV BIOL, V35, P71, DOI 10.1016/S0070-2153(08)60257-4
[2]   IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells [J].
Antoku, K ;
Liu, Z ;
Johnson, DE .
LEUKEMIA, 1998, 12 (05) :682-689
[3]  
Burtscher I, 1999, CANCER RES, V59, P3923
[4]  
Carson JP, 1999, CANCER RES, V59, P1449
[5]   REQUIREMENT FOR INTRINSIC PROTEIN TYROSINE KINASE IN THE IMMEDIATE AND LATE ACTIONS OF THE EGF RECEPTOR [J].
CHEN, WS ;
LAZAR, CS ;
POENIE, M ;
TSIEN, RY ;
GILL, GN ;
ROSENFELD, MG .
NATURE, 1987, 328 (6133) :820-823
[6]   Nucleotide-binding properties of kinase-deficient epidermal-grawth-factor-receptor mutants [J].
Cheng, KR ;
Koland, JG .
BIOCHEMICAL JOURNAL, 1998, 330 :353-359
[7]   A KINASE-NEGATIVE EPIDERMAL GROWTH-FACTOR RECEPTOR THAT RETAINS THE CAPACITY TO STIMULATE DNA-SYNTHESIS [J].
COKER, KJ ;
STAROS, JV ;
GUYER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :6967-6971
[8]   TRANSFER OF FUNCTIONAL EGF RECEPTORS TO AN IL3-DEPENDENT CELL-LINE [J].
COLLINS, MKL ;
DOWNWARD, J ;
MIYAJIMA, A ;
MARUYAMA, K ;
ARAI, KI ;
MULLIGAN, RC .
JOURNAL OF CELLULAR PHYSIOLOGY, 1988, 137 (02) :293-298
[9]   Take your partners, please - Signal diversification by the erbB family of receptor tyrosine kinases [J].
Daly, RJ .
GROWTH FACTORS, 1999, 16 (04) :255-263
[10]   Cellular survival: a play in three Akts [J].
Datta, SR ;
Brunet, A ;
Greenberg, ME .
GENES & DEVELOPMENT, 1999, 13 (22) :2905-2927